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Dietary Antimicrobials
in a Wean-to-Finish Facility
Michael C. Brumm1

Summary and Implications
The routine use of growthpromoting antimicrobial feed additives
is under increasing pressure worldwide. In response to this pressure, it is
important that producers and their
advisors understand under what circumstances these additives are likely
to be effective or ineffective, allowing
for improved decisions regarding their
use. An experiment was conducted to
examine the routine use of antimicrobial feed additives in a wean-to-finish
facility. The weaned pigs used in this
experiment were purchased from a
source where grow-finish pigs were
positive for PRRSV, circovirus-2 and
Mycoplasma hyopneumoniae and had
a previous history of Actinobacillus
pleuropneumoniae (APP) related
problems. Experimental treatments were
no growth-promoting antimicrobials
after the pre-starter diet versus continuous antimicrobial additions from
weaning to slaughter and day of weaning replicated in a 2 x 2 factorial. At
the end of the nursery phase eight weeks
after weaning, pigs fed diets containing antimicrobials were heavier
(P < 0.01) with less variation in weight
(P < 0.01). There was no effect of treatment on feed conversion efficiency for
this eight- week period. Pigs fed diets
containing antimicrobials also had less
severe diarrhea (P < 0.01) at six weeks
post-weaning. During the grow-finish
phase, diets meant to contain antimicrobials often assayed for lower
antimicrobial content than intended.
However, there were no mixing errors
such that pigs meant to receive diets
with no antimicrobials were offered
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diets containing antimicrobials or vice
versa. Pigs fed diets without antimicrobials grew faster (P < 0.05) with
improved feed conversion (P < 0.1)
during the grow-finish phase. Overall,
there was no effect of dietary antimicrobial addition on pig performance,
death loss, or carcass traits. In this
experiment, while the weaned pigs were
purchased from a source with known
health challenges, the pigs remained
very healthy, as evidenced by decreasing serum titers for APP and the lack
of seroconversion for PRRSV. These
results suggest that routine and continuous use of antimicrobial feed additives beyond the nursery stage in a
wean-to-finish facility with high-health
pigs should be evaluated on a case by
case basis.
Introduction
Recently, the World Health
Organization recommended that
pork production systems world wide
significantly reduce and eventually
stop the use of growth-promoting
antimicrobial feed additives. This
follows the decision of the Danish
government to ban their routine
use, other than by veterinary prescription, and the recommendation
of the European Union to ban
growth-promoting antimicrobial use
entirely. The basis for these recommendations is the belief that continuous additions of antimicrobials
to swine diets contributes to the
increasing public health problems
associated with bacterial resistance
to antimicrobials. In addition, many
groups supporting a ban suggest
that the response to growthpromoting antimicrobials in swine
diets is much less than in previous

years. Therefore, the financial
impact to the swine industry and
the impact on pig health and welfare will be minimal upon their
removal from the diet. However,
recent evidence suggests the
expected benefits to the antimicrobial ban have not been fully realized, resulting in an increased
incidence of pig scours and death
loss in Denmark, even though therapeutic use of antimicrobials has
increased.
Growth-promoting antimicrobials have been approved for use in
swine diets since the mid 1950s.
Traditionally, pigs fed diets containing these compounds have had
increased daily gain, improved feed
efficiency, decreased variation in
performance and improved health.
A limit to applying the traditional
data to today’s production systems
is that the health status of the pigs
was often never verified. Scientists
and regulators cannot answer the
question posed by producers, advisors and critics — under what
conditions can we expect a response
and when is it logical to expect
little or no response to antimicrobials?
The following experiment was
conducted to investigate the effect
of routine additions of growth promoting antimicrobials to swine
diets in a wean-to-finish facility
when pigs were purchased from a
source herd with known health challenges.
Methods
The experiment was conducted
at the University of Nebraska’s
Haskell Ag Lab Swine Research Unit

Table 1. Experimental diets.
Ingredient

Pre-starter

Corn
Soybean meal, 46.5% CP
Fat
Dicalcium PO , 18.5%
4
Limestone
L-lysine
a
Akey Vit/TM premix
Salt
b
Natuphos 600G
a
Akey 2000
a
Akey Prestart 650
a
Akey Start 350
a
Akey Start 100
Weight range, lb
Feed budget, lb/pig
Lysine,%

1

2

3

4

5

6

7

8

875
435
40

1050
550
50

1205
645
50

1230
665
60
15
17
2
4
6
1

1312
585
60
13
17
2
4
6
1

1384
520
60
6
17
2
4
6
1

1527
410
30
3
17
2
4
6
1

1680
260
30
0
17
2
4
6
1

40-60

60-90

90-135

135-190

190-mkt

1.21

1.10

1.01

0.87

0.67

2000
650
350
100
11.5-13
2.1
1.64

13-18
6.7
1.44

18-25
10.0
1.37

25-40
23.7
1.31

a
Akey
b

Inc, Lewisburg, OH
BASF Inc, Mt. Olive, NJ.

Table 2. Dietary antimicrobial additions for DRUG treatment.
Weight range, lb

Antimicrobial

Dietary addition, g/t

11.5-13

chlortetracycline (CTC)
tiamulin

400
35

13-25

bacitracin methylene disalicylate (BMD) 250
roxarsone
34.5

25-60

CTC
sulfamethazine
penicillin

100
100
50

60-market

BMD

30

75 (for 10 days)

CTC

135 (for 10 days)

CTC

400
(10 mg/lb of body weight/day)
560
(10 mg/lb of body weight/day)

near Concord, Neb. Pigs were
housed in a double curtain, naturally ventilated, fully slatted confinement facility with 16 pens and
daily fresh water, under slat flushing for manure removal. Each 8 ft x
14 ft pen contained 15 pigs and
contained one two-hole wean-tofinish feeder and one wean-tofinish cup drinker.
The experimental treatments
were:
1) Continuous dietary additions of growth promoting
antimicrobials (Drug) vs
none (Control)
2) Date of weaning

Diets were corn-soybean meal
based and formulated according to
the recommendations of Akey, Inc.
(Lewisburg, OH) from weaning to
40 pounds bodyweight and according to the University of Nebraska
recommendations for high lean gain
pigs thereafter (Table 1). The prestarter diet contained 400 g/t of
chlortetracycline and 35 g/t of
tiamulin for all pigs. Both the prestarter and Diet 1 contained 2,310
ppm zinc as zinc oxide. All remaining diets were in meal form with or
without the appropriate growthpromoting feed additive (Table 2).
From weaning until 40 lb body

weight, pigs were fed according to
the feed budget included in Table
1. From 40 lb body weight to slaughter, diets were switched on the week
a pen achieved the target weight.
Each delivery of feed was sampled
and assayed for antimicrobial content by Alpharma Inc.
Two-hundred and forty newly
weaned pigs (DK33 dam x Danbred
NA sire; 15-21 days old) were purchased from a herd where growfinish pigs were positive for PRRSV,
circovirus-2 and Mycoplasma
hyopneumoniae. The source herd also
had a previous history of Actinobacillus pleuropneumoniae (APP).
On the day of weaning, pigs
were transported to the research
facility, eartagged, weighed and
ranked within sex by weight.
Every weight outcome group of eight
pigs within sex was randomly
assigned to pens. Pigs were weaned
on Sept. 16 and Sept. 18, with 120
head delivered each day.
Approximately 2.5 weeks postweaning, all pigs received a commercial electrolyte and citric acid
in the water for five days as a preventative treatment for gut edema
caused by beta-hemolytic E. coli.
Pigs were vaccinated via the water
for erysipelas at 8 weeks postweaning.
(Continued on next page)
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Table 3. Effect of experimental treatments on pig performance.
Treatments
Dietary Drug

Wean Date

P Values

Item

No

Yes

9/16/02

9/18/02

No. pens

8

8

8

8

11.4
63.9
257.7

11.4
69.4
255.2

11.8
70.8
261.9

Coefficient of variation of pig weight within a pen, %
Wean
20.3
22.1
b
Day 57
18.8
14.8
c
10.1
9.3
Final

21.9
14.4
9.5

Pig weight, lb
Wean
b
Day 57
c
Final

SE

Drug

10.9
62.4
251.0

<0.1
0.8
2.6

NS
<0.01
NS

<0.01
0.01
0.05

20.6
19.2
10.0

0.8
0.8
0.8

NS
<0.01
NS

NS
<0.01
NS

a

Wean

Average daily gain, lb
a
Wean-day 57
b
Day 57 - final
Overall

0.94
1.85
1.53

1.03
1.77
1.52

1.04
1.82
1.54

0.94
1.80
1.50

0.01
0.02
0.02

<0.01
<0.05
NS

<0.01
NS
<0.1

Average daily feed, lb
b
Wean-day 57
b
Day 57 -final
Overall

1.57
5.45
4.09

1.70
5.32
4.05

1.71
5.40
4.10

1.56
5.38
4.03

0.02
0.07
0.05

<0.01
NS
NS

<0.01
NS
NS

Feed:gain
b
Wean-day 57
b
Day 57 -final
Overall

1.67
2.96
2.67

1.65
3.01
2.67

1.66
2.97
2.66

1.67
2.99
2.69

0.02
0.02
0.02

NS
<0.01
NS

NS
NS
NS

0.80
2.74
54.80
48.31
196.7

0.83
2.75
54.60
48.13
193.6

0.81
2.75
54.80
48.31
198.8

0.83
2.74
54.70
48.13
191.4

0.02
0.02
0.01
0.28
1.6

NS
NS
NS
NS
NS

NS
NS
NS
NS
<0.01

IBP, Inc.
Backfat, in.
Loin depth, in.
% lean
Carcass value, $/cwt
Hot carcass wt., lb
a
NS = not significant (P > 0.1).
b
Day 58 and day 56 for pigs weaned
c

on 9/16 and 9/18, respectively.
Day 163 and day 161 for pigs weaned on 9/16 and 9/18, respectively.

At weaning, one barrow and
one gilt per pen were randomly
selected, and these pigs were bled
via vena puncture on week 0, 4, 8,
12, 16, 20 and before slaughter.
Serum was harvested and frozen
for subsequent serology profiling.
All pigs that died during the
experiment were examined for cause
of death by a consulting veterinarian. Pen size was not adjusted in
the event of pig death. A record
was maintained of any injectable
antibiotic use for treatment of lameness, obvious respiratory distress,
etc. No water-soluble antimicrobials were administered to either
treatment group.
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All pigs were slaughtered on
the same day at IBP Inc at Madison,
Neb. Pigs were identified with tattoo by sex within pen and carcass
data was collected by IBP employees.
Results were analyzed as a complete random design using a 2 x 2
factorial arrangement of treatments
using the GLM procedure of SAS
with the pen of pigs as the experimental unit. The model included
weaning date, use of feed additive
and the interaction of these main
effects.

Results and Discussion
On Oct. 30 (days 42 and 44 postweaning), many pens of pigs were
noted to have diarrhea. The pens
were scored for severity of diarrhea, by a veterinarian without
knowledge of the dietary treatment
assignments, using a 1 to 3 scale
with 1 being normal feces and 3
being severe diarrhea. The average
scores were 1.25 for pens with diets
containing feed additives (Drug)
and 1.88 for Control pens (P < 0.01).
No samples were collected for submission to a veterinary diagnostic
laboratory and within two weeks
there were no differences noted
among the pens for diarrhea.

Three pigs died during the
experiment. Death loss could was
not related to either of the experimental treatments. Use of injectable and antimicrobials to treat
individual pigs was minimal and
also not related to the experimental
treatments.
At the end of the experiment,
frozen serum samples from the
bleedings on weeks 0, 12 and just
before slaughter were submitted to
the University of Nebraska Veterinary Diagnostic Laboratory. All
samples were negative for PRRSV
other than three samples thought
to be false positives. Several pigs
were positive (complement fixation
test) for APP at weaning. However,
the titers declined over time, suggesting no active infection. Thus,
the pigs maintained a relatively high
health status during the experiment,
in spite of the attempt to identify a
source of pigs with health challenges
often encountered in production
systems.
Pig performance is presented
in Table 3. There were no interactions between weaning day and
dietary treatments (P > 0.1) except
for coefficient of variation (CV) for
pig weight within the pen on day
57. Day 57 in the table is day 58 for
pigs weaned on Sept. 16 and day
56 for pigs weaned on Sept. 18.
The interaction for CV on day 57
(P < 0.05) is due to the amount of
the response to the experimental
treatments, and not due to a difference in response. For pigs weaned
on Sept. 16, the CV for within pen
weight on day 57 was 14.8% and
14.0% and for pigs weaned on Sept.
18, the CV was 22.8% and 15.5%,
for Control and Drug treatments,
respectively.
For the first eight weeks postweaning, pigs given diets that
included growth promoting feed
additives grew faster (1.03 vs 0.94
lb/d; P < 0.01) with no difference in
feed conversion. Because they grew

faster, pigs given diets that included
growth promoting feed additives
were 5.5 pounds heavier (69.4 vs
63.9 lb; P < 0.01) and had less weight
variation within the pen (day 57
CV 14.8% vs 18.8%; P <0 .01) on day
57 of the trial..
However, during the period
from day 57 to final, pigs given
diets containing no growth promoting additives grew faster (1.85 vs
1.77 lb/d; P< 0.05) and were slightly
more efficient (2.96 vs 3.01 lb/lb;
P < 0.1). Much of this difference in
performance occurred during the
two-week period from day 57 to
day 71. During this period, pigs
given diets with no growth promoting feed additive grew faster
(1.87 vs 1.74 lb/d; P< 0.05) and
were more efficient (2.08 vs 2.25;
P< 0.05). There was no effect of
dietary antimicrobial treatment on
any carcass parameter. The heavier
hot carcass weight for pigs weaned
on Sept. 16 vs Sept. 18 is a reflection
of the heavier weaning weight
(P< 0.01), faster overall daily gain
(P<.1) and heavier final weight
(P< 0.05). Date of weaning had no
effect (P> 0.1) on any other carcass
parameter.
Possibilities for why the
improvement in performance during the nursery phase was not
maintained during the grow-finish
phase for pigs fed diets containing
antimicrobials include the health
status of the pigs and possible mixing errors at the feedmill. In spite of
identifying a source of pigs from a
herd with known health challenges
in growing-finishing pigs, the pigs
used in this experiment remained
very healthy, possibly due to the
smaller number of pigs in the facility. There were 240 pigs in the
research facility, while in commercial facilities it is common to have
500-1,000 or more pigs per air space.
The source herd often had this many
pigs in various facilities.

The research diets were mixed
at a commercial mill and every
delivery was assayed for antimicrobial additions. All of the control diets were negative for
antimicrobial additions. The U.S.
Food and Drug Administration
(FDA) allows assays for bacitracin
methylene disalicylate (BMD) to
vary +/- 30%, or feeds with 30 gm/
ton additions to assay at 21 to 39
gm/ton and still be considered as
meeting the label claim for 30 g/t
additions. All assays were less than
30 g/t, with several less than 19
g/ton. Thus, the lack of response
during the grow-finish phase may
have been due in part to the lower
than intended level of addition of
BMD. Assays for the other antimicrobial additions to the diets were
generally within US-FDA accepted
ranges.
Conclusions
In this experiment, the use of
antimicrobial growth promoting
feed additives improved daily gain,
reduced within pen weight variation for the first eight weeks postweaning, and reduced the severity
of diarrhea. However, during the
grow-finish phase there was no
overall effect of antimicrobials in
the diet. These data suggest that
the use of antimicrobial growth
promoting feed additives remains
an effective management tool during the nursery phase of production. However, there was no
response during the grow-finish
phase, possibly due to the very high
health status of the pigs or lower
than intended level of antimicrobial additions.

1
Michael C. Brumm is a professor and
Extension swine specialist at the Northeast
Research and Extension Center, Concord,
Neb.
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